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The effects of various concentrations of aqueous extract of Vernonia amygdalina leaves on some 
biochemical indices of liver function were investigated in albino Wistar rats. Acute toxicity tests of the 
extract gave an LD50 of 500 mg/kg. Phytochemical analysis of the plant material showed that anthracene 
glycosides, steroids, flavonoids, proteins, carbohydrates, reducing sugars, saponins and tannins were 
present. Liver function tests revealed that the activity of aspartate aminotransferase (AST) increased 
significantly (p<0.05) for all the concentrations administered. There was no significant (p>0.05) increase 
in both alanine aminotransferase and alkaline phosphatase activities for all the concentrations 
administered. Also the increase in mean values of conjugated and unconjugated bilirubin for all the 
concentrations administered were not statistically significant (p>0.05). The results, therefore, strongly 
suggest that V. amygdalina leaf extract is not hepatotoxic in rats. The findings are of nutritional, clinical 
and veterinary relevance considering the diverse applications of the plant in almost all African 
populations.   
  





Vernonia amygdalina Del. popularly known as bitter leaf 
is a shrub of 2-5 m tall with petiolate green leaves of 
about 6 mm diameter. The leaves are characteristically 
bitter but the bitterness can be abated by boiling or by 
soaking in several changes of clean water (Burkill, 1985). 
The stem and root divested of the bark are used as 
chew-sticks in Nigeria. More importantly, the leaves are a 
very popular soup vegetable and have even been 
reported to be consumed by goats in some parts of 
Nigeria (Aregheore et al., 1998). 
All parts of the plant are pharmacologically useful.  The 
roots and the leaves are used in ethnomedicine to treat 
fever, hiccups, kidney problems and stomach discomfort 
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Saffaf, 1994). ). Both aqueous and alcoholic extracts of 
the stem, bark, roots and leaves are reported to be 
extensively used as a purgative, antimalarial and in the 
treatment of eczema (Kupcham, 1971). The plant has 
acquired special relevance  recently, having been proved 
in human medicine to possess potent antimalarial and 
antihelminthic properties (Abosi and Raseroka, 2003) as 
well as antitumorigenic properties (Izevbigie et al., 2004) 
with an amazing antiparasitic efficacy in zoopharmacog-
nosy as it is easily recognized and used for self-
medication by parasitized chimpanzees (Huffman, 2003).  
Pharmacological studies have also shown that the leaf 
extract has both hypoglycaemic and hypolipidaemic 
properties in experimental animals and so could be used 
in managing diabetes mellitus (Akah, 1992). The active 
components of the plant have been shown to be mainly 
sesquiterpene lactones like vernodalin and vernoamyg-
dalin and steroid glycosides like vernonioside B1 and 





Nutritionally, V. amygdalina is used mainly in soup 
making in the tropics and also as an appetizer and 
febrifuge (Ijeh et al., 1996; Iwu, 1996) and has proven to 
be a successful supplement in weaning foods (Eleyinmi, 
2005). In Nigeria, as in other tropical countries of Africa 
where the daily diet is dominated by starchy staple foods, 
vegetables are the cheapest and most readily available 
sources of important proteins, vitamins, minerals and 
essential amino acids (Okafor 1983). The importance of 
V. amygdalina in animal nutrition in Nigeria has also been 
well documented (Onwuka et al., 1989; Aregheore et al., 
1998).   
Despite these varied uses of the plant, there has been 
insufficient information on its exact toxicological 
potentials on the animal system. There have been reports 
of the presence of toxic phytochemicals (Aregheore et al., 
1997; Bonsi et al., 1995). There are also reports of actual 
hepatotoxicity in mice (Igile et al., 1995), yet there is a 
report that extracts from the plant are able to inhibit and 
even reverse carbon tetrachloride-induced hepatotoxicity 
in rats (Babalola et al., 2001). This study was therefore 
designed primarily to examine the actual effect of an 
aqueous extract of V. amygdalina leaves on some 
biochemical parameters of l iver integrity in rats 
and also to examine the response of the animals to acute 
toxicity tests using extracts of the plant. 
 
 
MATERIALS AND METHODS 
 
Preparation, crude extract administration and bioassay  
 
Pesticide-free fresh leaves of V. amygdalina were collected from 
within Owerri, Imo State, Nigeria and the botanical identity kindly 
confirmed by Dr. S. E. Okeke of the Department of Plant Biology 
and Biotechnology, Imo State University, Owerri, Nigeria where 
voucher samples were kept for reference. Healthy fresh leaves 
were sorted, washed to remove debris and dust particles without 
squeezing and then sun-dried for four days before the final drying in 
an oven at 65oC for 24 h. The dried leaves were milled into a 
coarse powder from which 25 g was soaked with 250 ml of distilled 
water in a beaker and the mixture shaken on the laboratory bench 
for 24 h before filtering. The filtrate was evaporated using a rotary 
evaporator to obtain a solid residue (2.4 g) called the aqueous 
extract. Appropriate weights of the residue were prepared in 




Acute toxicity tests 
 
The acute toxicity of the extract was tested using 30 Wistar albino 
rats divided into 5 groups of 6 rats each, with each group receiving 
a different dose of the extract administered intraperitoneally as 
described by Miller and Tainter (1944). The number of deaths in 
each group within 24 h was recorded. The LD50 was estimated from 
the graph of percentage (%) mortality (converted to probit) against 
log-dose of the extract, probit 5 being 50%. 
 
 
Liver function tests 
 
Eighteen albino Wistar strain rats were randomly assigned into 3 
groups  of  six  rats each  and  housed in stainless  steel  cages and 




kept in a room where a 12-h light/dark cycle was maintained. They 
were allowed access to water and feed diet (product of Pfizer 
Nigeria Ltd.) ad libitum throughout the period of the experiment. In  
addition, Group I (the high dose group) received 100 mg extract/kg  
body weight while Group II (the low dose group) received 50 mg/kg 
body weight administered through the intraperitoneal (i.p) route 
twice daily for four days. Group III (the control group) was 
maintained on feed diet and water only. 
24 h after the last injection all rats were weighed and sacrificed 
under chloroform anesthesia and with a sterile syringe and needle, 
8 ml of blood was collected from each animal by cardiac puncture 
and transferred into a centrifuge tube and allowed for 30 min to clot 
before centrifuging using Wisperfuge Model 1384 centrifuge 
(Tamson, Holland) for 5 min and the resulting supernatant used for 
the assessment of liver integrity. 
Total and conjugated bilirubins were determined according to the 
method of Malloy and Evelyn (1937) as modified by Tietz (1976). 
Total bilirubin was determined in the presence of caffeine benzoate 
which releases albumin-bound bilirubin. Bilirubin then reacts with 
diazotized sulphanilic acid to form pink-coloured azobilirubin which 
in the presence of alkaline tartarate is converted to a green colour. 
Aspartate and alanine aminotransferases were assayed by the 
method of Reitman and Frankel (1957) while alkaline phosphatase 
activity was assayed using disodium phenol phosphate as substrate 





Data collected were summarized as mean ± SD. Differences 
between individual groups were assessed by student’s t-test. A P-
value  0.05 was considered significant. 
 
 
RESULTS AND DISCUSSION  
 
The acute toxicity studies produced an LD50 of 500 mg/kg 
body weight of experimental animal. Table 1 shows the 
results of serum bilirubin levels for the animals.  The 
differences in the mean values of total, conjugated and 
unconjugated bilirubin concentrations in groups I and II 
were not significant when compared with the control 
group or with one another (P>0.05). Table 2 shows the 
result of the administration of aqueous leaf extract of V. 
amygdalina on some liver function diagnostic enzymes.  
The results show no significant increase in total, 
conjugated and unconjugated bilirubin levels between the 
various groups. Also, the activities of both alanine 
aminotransferase and alkaline phosphatase in the 
presence of V. amygdalina leaves extract increased 
slightly in a dose-dependent manner when compared 
with the control but none of these observed slight 
increases was statistically significant (P>0.05) when 
compared to the control or when compared within doses. 
The result showed, however, that the aspartate aminotra-
nsferase activity significantly (P<0.05) increased in both 
the low-dose and high-dose groups when compared with 
the control group. There was also a significant dose-de-
pendent difference in the activities of the high-dose and 
the low-dose groups.  
The elevations in liver function parameters as found in 
this work are not such that should  discourage the  indica-  




Table 1. Concentration of serum bilirubin in rats fed V. amygdalina leaves extract. 
 
Parameter High dose Low dose Control 
Total bilirubin (mg/100ml) 1.14±0.15 1.08±0.11 0.88±0.08 
Conjugated bilirulim (mg/100ml) 0.62±0.08 0.53±0.07 0.4±0.18 
Unconjugated bilirulim (mg/100ml) 0.52±0.06 0.55±0.3 0.48±0.10 
 
 
Table 2. Activities of serum liver diagnostic enzymes in rats fed V. amygdalina leaves extract. 
 
Enzyme (IU/L) High dose Low dose Control 
Alanine aminotransferase 22.4±1.84 20.0±1.64 18.6±1.52 
Aspartate aminotransferase 44.4±1.1.68** 30.4±1.96* 10.6±1.34 
Alkaline phosphatase     104.15±5.36 101.6±5.2 88.4±4.26 
 
*Significantly different from control group (P<0.05) 




tes its nonhepatotoxic effect. Alanine aminotransferase is 
a more reliable marker of liver integrity than aspartate 
aminotransferase. The observed significant increase in 
the activity of aspartate aminotransferase alone may 
therefore be of extrahepatic origin. We are currently 
testing this extrahepatic hypothesis. 
Furthermore, the acute toxicity studies show an LD50 of 
500 mg/kg body weight. This indicates that the vegetable 
when consumed in high quantities may, indeed, elicit 
hepatotoxicity as observed in small animals like mice by 
Igile and co-workers (1995). Such very large quantities of 
the vegetable are, however, not consumed at the same 
time. It is therefore, unlikely that consumption at any time 
will attain toxic levels. Even at this, the toxic value in our 
present work was obtained for an unprocessed aqueous 
extract of the vegetable. Traditionally, however, the 
vegetable is macerated and the dilute extract 
administered for therapeutic purposes while in nutritional 
applications, the leaves are soaked and washed severally 
in clean water prior to its use in soup making. Some 
times, the washed vegetables are sun-dried and then 
used installmentally. Such processing methods have 
been shown to detoxify several leafy vegetables that are 
ordinarily very toxic in their raw state, including the more 
popular vegetable Telfaria occidentalis (fluted pumpkin).  
This side of the logic may then explain why even 
though antinutritional factors were shown to be present in 
V. amygdalina (Eleyinmi et al., 2005), nutritional studies 
on the same vegetable after the traditional processing 
methods gave very commendable results (Eleyinmi et 
al.,). This may also explain why processed extracts from 
the plant were able to inhibit and even reverse carbon 
tetrachloride-induced hepatotoxicity in rats as observed 
by Babalola and his co-workers (2001). 
Our findings confirm that V. amygdalina leaves may be 
toxic (just like several other vegetables) if consumed in 
very large quantities but the potential danger is not higher 
than has been observed for other common vegetables 
that are routinely consumed in Africa in even larger 
quantities. Our results do not confirm hepatotoxic effects 
of the vegetable, at least, in rats. The several useful 
applications of the vegetable in both human and 
veterinary nutrition and medicare should, however, take 
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